Oramed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORMP and other ETFs, options, and stocks.About ORMP
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides.
CEONadav Kidron
CEONadav Kidron
Employees13
Employees13
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2002
Founded2002
Employees13
Employees13
ORMP Key Statistics
Market cap107.47M
Market cap107.47M
Price-Earnings ratio2.68
Price-Earnings ratio2.68
Dividend yield—
Dividend yield—
Average volume172.19K
Average volume172.19K
High today$2.77
High today$2.77
Low today$2.67
Low today$2.67
Open price$2.70
Open price$2.70
Volume40.61K
Volume40.61K
52 Week high$3.09
52 Week high$3.09
52 Week low$1.82
52 Week low$1.82
Stock Snapshot
The current Oramed Pharmaceuticals(ORMP) stock price is $2.68, with a market capitalization of 107.47M. The stock trades at a price-to-earnings (P/E) ratio of 2.68.
During the trading session on 2025-12-09, Oramed Pharmaceuticals(ORMP) shares reached a daily high of $2.77 and a low of $2.67. At a current price of $2.68, the stock is +0.6% higher than the low and still -3.2% under the high.
Trading volume for Oramed Pharmaceuticals(ORMP) stock has reached 40.61K, versus its average volume of 172.19K.
Over the past 52 weeks, Oramed Pharmaceuticals(ORMP) stock has traded between a high of $3.09 and a low of $1.82.
Over the past 52 weeks, Oramed Pharmaceuticals(ORMP) stock has traded between a high of $3.09 and a low of $1.82.
People also own
Based on the portfolios of people who own ORMP. This list is generated using Robinhood data, and it’s not a recommendation.